1 Benjamin, E. J. et al. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation 137, e67-e492, doi:10.1161/cir.0000000000000558 (2018).
2 Chugh, S. S. Sudden cardiac death in 2017: Spotlight on prediction and prevention. Int J Cardiol 237, 2-5, doi:10.1016/j.ijcard.2017.03.086 (2017).
3 Zheng, Z. J., Croft, J. B., Giles, W. H. & Mensah, G. A. Sudden cardiac death in the United States, 1989 to 1998. Circulation 104, 2158-2163 (2001).
4 Roy, D. et al. Long-term reproducibility and significance of provokable ventricular arrhythmias after myocardial infarction. J Am Coll Cardiol 8, 32-39 (1986).
5 Marchlinski, F. E., Waxman, H. L., Buxton, A. E. & Josephson, M. E. Sustained ventricular tachyarrhythmias during the early postinfarction period: electrophysiologic findings and prognosis for survival. J Am Coll Cardiol 2, 240-250 (1983).
6 Jackson, N., Gizurarson, S., Massé, S. & Nanthakumar, K. in Cardiac Electrophysiology: From Cell to Bedside, 2018 (eds D. P. Zipes, J. Jalife, & W. G. Stevenson) Ch. 48.
7 Tomaselli, G. F. & Zipes, D. P. What causes sudden death in heart failure? Circ Res 95, 754-763, doi:10.1161/01.RES.0000145047.14691.db (2004).
8 Tomaselli, G. F. & Marbán, E. Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res 42, 270-283, doi:10.1016/s0008-6363(99)00017-6 (1999).
9 Pu, J. & Boyden, P. A. Alterations of Na+ currents in myocytes from epicardial border zone of the infarcted heart. A possible ionic mechanism for reduced excitability and postrepolarization refractoriness. Circ Res 81, 110-119 (1997).
10 Wit, A. L. & Peters, N. S. The role of gap junctions in the arrhythmias of ischemia and infarction. Heart Rhythm 9, 308-311, doi:10.1016/j.hrthm.2011.09.056 (2012).
11 Gilmour, R. F., Jr., Heger, J. J., Prystowsky, E. N. & Zipes, D. P. Cellular electrophysiologic abnormalities of diseased human ventricular myocardium. The American journal of cardiology 51, 137-144, doi:10.1016/s0002-9149(83)80024-1 (1983).
12 Gessert, S. & Kühl, M. The multiple phases and faces of wnt signaling during cardiac differentiation and development. Circ Res 107, 186-199, doi:10.1161/circresaha.110.221531 (2010).
13 Liang, W. et al. Canonical Wnt signaling promotes pacemaker cell specification of cardiac mesodermal cells derived from mouse and human embryonic stem cells. Stem Cells 38, 352-368, doi:10.1002/stem.3106 (2020).
14 Hou, N. et al. Transcription Factor 7-like 2 Mediates Canonical Wnt/beta-Catenin Signaling and c-Myc Upregulation in Heart Failure. Circ Heart Fail 9:e003010, doi:10.1161/CIRCHEARTFAILURE.116.003010 e003010
10.1161/circheartfailure.116.003010 (2016).
15 Duan, J. et al. Wnt1/betacatenin injury response activates the epicardium and cardiac fibroblasts to promote cardiac repair. Embo J 31, 429-442, doi:10.1038/emboj.2011.418 (2012).
16 Dawson, K., Aflaki, M. & Nattel, S. Role of the Wnt-Frizzled system in cardiac pathophysiology: a rapidly developing, poorly understood area with enormous potential. J Physiol 591, 1409-1432, doi:10.1113/jphysiol.2012.235382 (2013).
17 Iyer, L. M. et al. A context-specific cardiac β-catenin and GATA4 interaction influences TCF7L2 occupancy and remodels chromatin driving disease progression in the adult heart. Nucleic Acids Res 46, 2850-2867, doi:10.1093/nar/gky049 (2018).
18 Malekar, P. et al. Wnt signaling is critical for maladaptive cardiac hypertrophy and accelerates myocardial remodeling. Hypertension 55, 939-945, doi:10.1161/HYPERTENSIONAHA.109.141127 (2010).
19 Zhao, Y. et al. An essential role for Wnt/β-catenin signaling in mediating hypertensive heart disease. Sci Rep 8, 8996, doi:10.1038/s41598-018-27064-2 (2018).
20 Bergmann, M. W. WNT signaling in adult cardiac hypertrophy and remodeling: lessons learned from cardiac development. Circ Res 107, 1198-1208, doi:10.1161/circresaha.110.223768 (2010).
21 Borrell-Pages, M. et al. LRP5/canonical Wnt signalling and healing of ischemic myocardium. Basic Res Cardiol 111, 67, doi:10.1007/s00395-016-0585-y (2016).
22 Liang, W., Cho, H. C. & Marban, E. Wnt signalling suppresses voltage-dependent Na(+) channel expression in postnatal rat cardiomyocytes. J Physiol 593, 1147-1157 (2015).
23 Lu, A. et al. Direct and indirect suppression of Scn5a gene expression mediates cardiac Na+ channel inhibition by Wnt signalling. Can J Cardiol 36, 564-576, doi:https://doi.org/10.1016/j.cjca.2019.09.019 (2020).
24 Lu, A. et al. Inhibition of β-catenin Increases Voltage-gated Na + Current in Brugada Syndrome Cardiomyocytes (March 30, 2021). Available at SSRN: https://ssrn.com/abstract=3815857 or http://dx.doi.org/10.2139/ssrn.3815857 (2021).
25 Wang, N. et al. Activation of Wnt/beta-catenin signaling by hydrogen peroxide transcriptionally inhibits NaV1.5 expression. Free Radic Biol Med 96, 34-44, doi:10.1016/j.freeradbiomed.2016.04.003 (2016).
26 Zhao, L., Sun, L., Lu, Y., Li, F. & Xu, H. A small-molecule LF3 abrogates beta-catenin/TCF4-mediated suppression of NaV1.5 expression in HL-1 cardiomyocytes. J Mol Cell Cardiol 135, 90-96, doi:10.1016/j.yjmcc.2019.08.007 (2019).
27 Gillers, B. S. et al. Canonical wnt signaling regulates atrioventricular junction programming and electrophysiological properties. Circ Res 116, 398-406, doi:10.1161/CIRCRESAHA.116.304731 (2015).
28 Li, G. et al. Differential Wnt-mediated programming and arrhythmogenesis in right versus left ventricles. J Mol Cell Cardiol 123, 92-107, doi:10.1016/j.yjmcc.2018.09.002 (2018).
29 Hahn, J. Y. et al. Beta-catenin overexpression reduces myocardial infarct size through differential effects on cardiomyocytes and cardiac fibroblasts. J Biol Chem 281, 30979-30989, doi:10.1074/jbc.M603916200 (2006).
30 Oikonomopoulos, A. et al. Wnt signaling exerts an antiproliferative effect on adult cardiac progenitor cells through IGFBP3. Circ Res 109, 1363-1374, doi:10.1161/circresaha.111.250282 (2011).
31 Barandon, L. et al. Reduction of infarct size and prevention of cardiac rupture in transgenic mice overexpressing FrzA. Circulation 108, 2282-2289, doi:10.1161/01.cir.0000093186.22847.4c (2003).
32 Zelarayán, L. C. et al. Beta-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation. Proc Natl Acad Sci U S A 105, 19762-19767, doi:10.1073/pnas.0808393105 (2008).
33 Gharibeh, L. et al. GATA6 is a regulator of sinus node development and heart rhythm. Proc Natl Acad Sci U S A 118, doi:10.1073/pnas.2007322118 (2021).
34 Cruciat, C. M. & Niehrs, C. Secreted and transmembrane wnt inhibitors and activators. Cold Spring Harbor perspectives in biology 5, a015081, doi:10.1101/cshperspect.a015081 (2013).
35 Bao, J., Zheng, J. J. & Wu, D. The structural basis of DKK-mediated inhibition of Wnt/LRP signaling. Science signaling 5, pe22, doi:10.1126/scisignal.2003028 (2012).
36 Valenta, T., Hausmann, G. & Basler, K. The many faces and functions of beta-catenin. Embo J 31, 2714-2736, doi:10.1038/emboj.2012.150 (2012).
37 Wang, Z. et al. Wnt signaling activates MFSD2A to suppress vascular endothelial transcytosis and maintain blood-retinal barrier. Sci Adv 6, eaba7457, doi:10.1126/sciadv.aba7457 (2020).
38 Yang, S. & Huang, X. Y. Ca2+ influx through L-type Ca2+ channels controls the trailing tail contraction in growth factor-induced fibroblast cell migration. J Biol Chem 280, 27130-27137, doi:10.1074/jbc.M501625200 (2005).
39 Pride, Y. B. et al. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction. The American journal of cardiology 104, 475-479, doi:10.1016/j.amjcard.2009.04.005 (2009).
40 Alexandre, J. et al. Scar extent as a predictive factor of ventricular tachycardia cycle length after myocardial infarction: implications for implantable cardioverter-defibrillator programming optimization. Europace 16, 220-226, doi:10.1093/europace/eut289 (2014).
41 Josephson, M. E., Horowitz, L. N. & Farshidi, A. Continuous local electrical activity. A mechanism of recurrent ventricular tachycardia. Circulation 57, 659-665, doi:10.1161/01.cir.57.4.659 (1978).
42 Wang, N. C. et al. Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction. Jama 299, 2656-2666, doi:10.1001/jama.299.22.2656 (2008).
43 Dhingra, R. et al. Electrocardiographic QRS duration and the risk of congestive heart failure: the Framingham Heart Study. Hypertension 47, 861-867, doi:10.1161/01.hyp.0000217141.20163.23 (2006).
44 He, B. J., Boyden, P. & Scheinman, M. Ventricular arrhythmias involving the His-Purkinje system in the structurally abnormal heart. Pacing and clinical electrophysiology : PACE 41, 1051-1059, doi:10.1111/pace.13465 (2018).
45 Puljevic, D., Smalcelj, A., Durakovic, Z. & Goldner, V. Effects of postmyocardial infarction scar size, cardiac function, and severity of coronary artery disease on QT interval dispersion as a risk factor for complex ventricular arrhythmia. Pacing and clinical electrophysiology : PACE 21, 1508-1516, doi:10.1111/j.1540-8159.1998.tb00237.x (1998).
46 Deb, A. Cell-cell interaction in the heart via Wnt/β-catenin pathway after cardiac injury. Cardiovasc Res 102, 214-223, doi:10.1093/cvr/cvu054 (2014).
47 Valenta, T., Hausmann, G. & Basler, K. The many faces and functions of β-catenin. Embo J 31, 2714-2736, doi:10.1038/emboj.2012.150 (2012).
48 Zuppinger, C., Eppenberger-Eberhardt, M. & Eppenberger, H. M. N-Cadherin: structure, function and importance in the formation of new intercalated disc-like cell contacts in cardiomyocytes. Heart failure reviews 5, 251-257, doi:10.1023/a:1009809520194 (2000).
49 Kuwabara, Y. et al. Increased expression of HCN channels in the ventricular myocardium contributes to enhanced arrhythmicity in mouse failing hearts. J Am Heart Assoc 2, e000150, doi:10.1161/jaha.113.000150 (2013).
50 Hofmann, F. et al. Ventricular HCN channels decrease the repolarization reserve in the hypertrophic heart. Cardiovasc Res 95, 317-326, doi:10.1093/cvr/cvs184 (2012).
51 Yue, L., Xie, J. & Nattel, S. Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovasc Res 89, 744-753, doi:10.1093/cvr/cvq329 (2011).
52 Percie du Sert, N. et al. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. Br J Pharmacol 177, 3617-3624, doi:10.1111/bph.15193 (2020).
53 Molgat, A. S. et al. Hyperglycemia inhibits cardiac stem cell-mediated cardiac repair and angiogenic capacity. Circulation 130, S70-76, doi:10.1161/circulationaha.113.007908 (2014).
54 Kapoor, N., Liang, W., Marban, E. & Cho, H. C. Direct conversion of quiescent cardiomyocytes to pacemaker cells by expression of Tbx18. Nat Biotechnol 31, 54-62, doi:10.1038/nbt.2465 (2013).
55 Liang, W. et al. Role of phosphoinositide 3-kinase {alpha}, protein kinase C, and L-type Ca2+ channels in mediating the complex actions of angiotensin II on mouse cardiac contractility. Hypertension 56, 422-429 (2010).
56 Jadhav, A. et al. Catharanthine dilates small mesenteric arteries and decreases heart rate and cardiac contractility by inhibition of voltage-operated calcium channels on vascular smooth muscle cells and cardiomyocytes. J Pharmacol Exp Ther 345, 383-392, doi:10.1124/jpet.112.199661 (2013).